Hyperpolarized Carbon-13 Pyruvate Imaging
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hyperpolarized Carbon-13 Pyruvate Imaging, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma [Phase 1]